BERRY: Effect of Blueberries on Cognition and Body Composition in Elderly With Mild Cognitive Decline

Sponsor
University of North Carolina, Chapel Hill (Other)
Overall Status
Completed
CT.gov ID
NCT01515098
Collaborator
(none)
123
1
3
37.9
3.2

Study Details

Study Description

Brief Summary

Purpose: The purpose of this study is to examine the effect of blueberry consumption on cognitive decline and body composition in humans.

Hypothesis 1: Adults with mild cognitive decline who consume blueberries will experience an improvement in cognitive abilities as measured by a standardized battery of tests, relative to those who consume a placebo.

Hypothesis 2: Adults with mild cognitive decline who consume blueberries will evidence an increase in processing speed and an improvement in memory abilities as measured in an electrophysiological paradigm and compared to those who consume a placebo.

Hypothesis 3: Daily intake of 35 g freeze-dried blueberries will improve body composition (fat mass vs. lean mass).

Hypothesis 4: Daily intake of 35 g freeze-dried blueberries will decrease oxidative stress and inflammatory markers.

Condition or Disease Intervention/Treatment Phase
  • Dietary Supplement: Freeze-dried blueberries
  • Dietary Supplement: Dextrose Placebo
N/A

Study Design

Study Type:
Interventional
Actual Enrollment :
123 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Triple (Participant, Investigator, Outcomes Assessor)
Primary Purpose:
Prevention
Official Title:
The Effect of Blueberry Consumption on Cognition and Body Composition in Elderly Who Are Experiencing Mild Cognitive Decline
Study Start Date :
Jan 1, 2012
Actual Primary Completion Date :
Mar 1, 2015
Actual Study Completion Date :
Mar 1, 2015

Arms and Interventions

Arm Intervention/Treatment
Experimental: Blueberry Group

37 grams of dehydrated blueberries daily for 6 months

Dietary Supplement: Freeze-dried blueberries
Wild blueberries, freeze-dried and pulverized

Placebo Comparator: Placebo Group

37 grams of dextrose powder daily for 6 months

Dietary Supplement: Dextrose Placebo
Placebo developed to closely match blueberry powder.

No Intervention: Reference Group

No intervention

Outcome Measures

Primary Outcome Measures

  1. Change in cognitive test performance [Baseline, 180 days]

    Measured by CANTAB

  2. Change in brain activity (N200, P300) related to cognitive abilities as measured by event-related potentials (ERP) [Baseline, 180 days]

    Recognition memory, speed of processing, and memory consolidation as measured by the electrophysiological technique known as event-related potentials (ERP)

Secondary Outcome Measures

  1. Change in body mass distribution [Baseline, 180 days]

    DXA scans to measure body composition at baseline and outcome will be compared for differences

  2. Change in oxidative stress and inflammatory markers as measured in blood and urine [Baseline, 180 days]

    Oxidative stress and inflammatory markers will be measured in blood and compared between baseline and outcome.

Eligibility Criteria

Criteria

Ages Eligible for Study:
65 Years to 79 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Men and women age 65 and older

  • BMI between 18.5 and 34.5

  • Close individual to report memory decline

Exclusion Criteria:
  • History of central nervous system or psychiatric disorders

  • Dementia or Alzheimer's diagnosis

  • Diabetes

  • Smoking >20 cigarettes/day

  • Gastrointestinal/digestive disorders

  • Uncontrolled chronic disease

Contacts and Locations

Locations

Site City State Country Postal Code
1 Nutrition Research Institute Kannapolis North Carolina United States 28081

Sponsors and Collaborators

  • University of North Carolina, Chapel Hill

Investigators

  • Principal Investigator: Carol L Cheatham, Ph.D., University of North Carolina, Chapel Hill

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Carol Cheatham, PhD, Assistant Professor of Psychology, University of North Carolina, Chapel Hill
ClinicalTrials.gov Identifier:
NCT01515098
Other Study ID Numbers:
  • 11-2075
First Posted:
Jan 23, 2012
Last Update Posted:
Mar 8, 2022
Last Verified:
Mar 1, 2022
Additional relevant MeSH terms:

Study Results

No Results Posted as of Mar 8, 2022